Details

Autor(en) / Beteiligte

• Schneider, Carolin V.
• Hamesch, Karim
• Gross, Annika
• Mandorfer, Mattias
• Moeller, Linda S.
• Pereira, Vitor
• Pons, Monica
• Kuca, Pawel
• Reichert, Matthias C.
• Benini, Federica
• Burbaum, Barbara
• Voss, Jessica
• Gutberlet, Marla
• Woditsch, Vivien
• Lindhauer, Cecilia
• Fromme, Malin
• Kümpers, Julia
• Bewersdorf, Lisa
• Schaefer, Benedikt
• Eslam, Mohammed
• Bals, Robert
• Janciauskiene, Sabina
• Carvão, Joana
• Neureiter, Daniel
• Zhou, Biaohuan
• Wöran, Katharina
• Bantel, Heike
• Geier, Andreas
• Dirrichs, Timm
• Stickel, Felix
• Teumer, Alexander
• Verbeek, Jef
• Nevens, Frederik
• Govaere, Olivier
• Krawczyk, Marcin
• Roskams, Tania
• Haybaeck, Johannes
• Lurje, Georg
• Chorostowska-Wynimko, Joanna
• Genesca, Joan
• Reiberger, Thomas
• Lammert, Frank
• Krag, Aleksander
• George, Jacob
• Anstee, Quentin M.
• Trauner, Michael
• Datz, Christian
• Gaisa, Nadine T.
• Denk, Helmut
• Trautwein, Christian
• Aigner, Elmar
• Strnad, Pavel

Titel

Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers

Ist Teil von

• Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.534-548.e11

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Homozygosity for the Pi∗Z variant of the gene that encodes the alpha-1 antitrypsin peptide (AAT), called the Pi∗ZZ genotype, causes a liver and lung disease called alpha-1 antitrypsin deficiency. Heterozygosity (the Pi∗MZ genotype) is a risk factor for cirrhosis in individuals with liver disease. Up to 4% of Europeans have the Pi∗MZ genotype; we compared features of adults with and without Pi∗MZ genotype among persons without preexisting liver disease. We analyzed data from the European Alpha-1 Liver Cohort, from 419 adults with the Pi∗MZ genotype, 309 adults with the Pi∗ZZ genotype, and 284 individuals without the variant (noncarriers). All underwent a comprehensive evaluation; liver stiffness measurements (LSMs) were made by transient elastography. Liver biopsies were analyzed to define histologic and biochemical features associated with the Pi∗Z variant. Levels of serum transaminases were retrieved from 444,642 participants, available in the United Kingdom biobank. In the UK biobank database, levels of serum transaminases were increased in subjects with the Pi∗MZ genotype compared with noncarriers. In the Alpha-1 Liver Cohort, adults with Pi∗MZ had lower levels of gamma-glutamyl transferase in serum and lower LSMs than adults with the Pi∗ZZ variant, but these were higher than in noncarriers. Ten percent of subjects with the Pi∗MZ genotype vs 4% of noncarriers had LSMs of 7.1 kPa or more (adjusted odds ratio, 4.8; 95% confidence interval, 2.0–11.8). Obesity and diabetes were the most important factors associated with LSMs ≥7.1 kPa in subjects with the Pi∗MZ genotype. AAT inclusions were detected in liver biopsies of 63% of subjects with the Pi∗MZ genotype, vs 97% of subjects with the Pi∗ZZ genotype, and increased with liver fibrosis stages. Subjects with the Pi∗MZ genotype did not have increased hepatic levels of AAT, whereas levels of insoluble AAT varied among individuals. Adults with the Pi∗MZ genotype have lower levels of serum transaminases, fewer AAT inclusions in liver, and lower liver stiffness than adults with the Pi∗ZZ genotype, but higher than adults without the Pi∗Z variant. These findings should help determine risk of subjects with the Pi∗MZ genotype and aid in counseling. [Display omitted]